Feb 26, 2026
针对此疑问,我们需要从利润结构、产能成本和市场份额三个维度来深度拆解礼来(Eli Lilly)和诺和诺德(Novo Nordisk)的受损程度。
Last report date: Sep 30, 2025
Company profile
NYSE exchange • Created Nov 22, 2025
Financial reports
3
Public filings from SEC EDGAR and company websites.
AI reports
1
Completed valuation analysis reports.
Last cutoff
Sep 30, 2025
Most recent financial reporting period.
Ticker price
USD 1008.39
Updated Mar 9, 2026
Fair value
??? (Subscribe to view)
Updated Nov 22, 2025